DK1304107T3 - Anvendelse af oxozolidinonderivater til behandling af psoriasis - Google Patents
Anvendelse af oxozolidinonderivater til behandling af psoriasisInfo
- Publication number
- DK1304107T3 DK1304107T3 DK02028171T DK02028171T DK1304107T3 DK 1304107 T3 DK1304107 T3 DK 1304107T3 DK 02028171 T DK02028171 T DK 02028171T DK 02028171 T DK02028171 T DK 02028171T DK 1304107 T3 DK1304107 T3 DK 1304107T3
- Authority
- DK
- Denmark
- Prior art keywords
- psoriasis
- oxozolidinone
- derivatives
- treatment
- phenylü
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title abstract 2
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract 1
- 229940030999 antipsoriatics Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6568997P | 1997-11-18 | 1997-11-18 | |
| US7129798P | 1998-01-16 | 1998-01-16 | |
| US7524798P | 1998-02-19 | 1998-02-19 | |
| EP98960157A EP1032386B1 (en) | 1997-11-18 | 1998-11-10 | Use of oxazolidinone derivatives for treating arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1304107T3 true DK1304107T3 (da) | 2005-08-22 |
Family
ID=34743570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02028171T DK1304107T3 (da) | 1997-11-18 | 1998-11-10 | Anvendelse af oxozolidinonderivater til behandling af psoriasis |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1304107B1 (da) |
| AT (1) | ATE299021T1 (da) |
| DE (1) | DE69830811T2 (da) |
| DK (1) | DK1304107T3 (da) |
| ES (1) | ES2243650T3 (da) |
| PT (1) | PT1304107E (da) |
| SI (1) | SI1304107T1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11608320B2 (en) | 2020-02-02 | 2023-03-21 | Kuwait University | Oxazolidinone hydroxamic acid derivatives |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU667198B2 (en) * | 1991-11-01 | 1996-03-14 | Pharmacia & Upjohn Company | Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents |
| SK283420B6 (sk) * | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| US5688792A (en) * | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| ATE182142T1 (de) * | 1993-11-22 | 1999-07-15 | Upjohn Co | Substituierte hydroxyacetyl piperazine phenyl oxazolidinonsäureester |
-
1998
- 1998-11-10 ES ES02028171T patent/ES2243650T3/es not_active Expired - Lifetime
- 1998-11-10 EP EP02028171A patent/EP1304107B1/en not_active Expired - Lifetime
- 1998-11-10 AT AT02028171T patent/ATE299021T1/de not_active IP Right Cessation
- 1998-11-10 DK DK02028171T patent/DK1304107T3/da active
- 1998-11-10 SI SI9830786T patent/SI1304107T1/xx unknown
- 1998-11-10 DE DE69830811T patent/DE69830811T2/de not_active Expired - Fee Related
- 1998-11-10 PT PT02028171T patent/PT1304107E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE299021T1 (de) | 2005-07-15 |
| EP1304107A2 (en) | 2003-04-23 |
| ES2243650T3 (es) | 2005-12-01 |
| PT1304107E (pt) | 2005-09-30 |
| DE69830811D1 (de) | 2005-08-11 |
| EP1304107B1 (en) | 2005-07-06 |
| DE69830811T2 (de) | 2006-04-27 |
| SI1304107T1 (en) | 2005-10-31 |
| EP1304107A3 (en) | 2003-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1574209T3 (da) | Fremgangsmåde til behandling af ophthalmiske sygdomme | |
| DK0867184T3 (da) | Anvendelse af tiagabin til behandling af søvnforstyrrelser | |
| DK0514452T4 (da) | Anvendelse af insulin-sensibiliserende midler til behandling af hypertension | |
| DK71387A (da) | Terapeutisk middel til behandling af psoriasis | |
| DK0655243T3 (da) | Melatoninderivater til anvendelse ved behandling af søvnlidelser | |
| ATE239470T1 (de) | Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen | |
| DE69301750D1 (de) | Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose | |
| DK0871446T3 (da) | Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve | |
| DK1304107T3 (da) | Anvendelse af oxozolidinonderivater til behandling af psoriasis | |
| ATE233092T1 (de) | Verwendung von oxazolidinonderivate zur behandlung von arthritis | |
| DE59813136D1 (de) | Verwendung von Thiaminen zur Herstellung eines Arzneimittels zur Prophylaxe und zur Therapie der diabetischen Retinopathie und der diabetischen Nephropathie | |
| PT821955E (pt) | Uso de 3-(4-hexiloxi-1,2,5-tiadiazol-3-il)-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina) para o tratamento da doenca bipolar | |
| DK664188A (da) | Butylhydroxyanisoler til behandling af retrovirale sygdomme | |
| TR199801801T2 (xx) | Madde k�t�ye kullan�m�n�n tedavisi. | |
| NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
| DE69800906D1 (de) | Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie | |
| DE3585312D1 (de) | Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden. | |
| NO984190L (no) | FremgangsmÕte for behandling av insomnia | |
| ATE150645T1 (de) | Verwendung von bmy 14802 zur behandlung von angstzuständen bei patienten mit benzodiazepin- entzugserscheinungen | |
| UA23921A (uk) | Спосіб лікування шлунково-стравохідного рефлюксу |